Chronic glucocorticoids consumption triggers and worsens experimental Alzheimer ’s disease-like pathology by detrimental immune-modulations
Conclusion: This study unravels new functional outco mes identifying chronic corticosterone consumption as a main risk factor for AD and suggests that glucocorticoid-based therapies should be prescribed with caution in populations with AD risk.
Source: Neuroendocrinology - Category: Endocrinology Source Type: research
More News: Alzheimer's | Brain | Endocrinology | Environmental Health | Neurology | Pathology | Study | Toxicology